1. The Extensive Regulation of MicroRNA in Immune Thrombocytopenia
   Yuerong Zhao et al, 2022, Clinical and Applied Thrombosis/Hemostasis CrossRef
2. Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
   Yue Lv et al, 2022, Frontiers in Immunology CrossRef
3. miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K/Akt and p53 in Immune Thrombocytopenia
   Yanan Wang et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
4. Current Status and Future Prospects of Perinatal Stem Cells
   Paz de la Torre et al, 2020, Genes CrossRef
5. The Mechanistic Effects and Clinical Applications of Various Derived Mesenchymal Stem Cells in Immune Thrombocytopenia
   Yue He et al, 2022, Acta Haematologica CrossRef
6. Therapeutic potential of MSCs and MSC-derived extracellular vesicles in immune thrombocytopenia
   Feifeng Wu et al, 2023, Stem Cell Research & Therapy CrossRef
7. Role of bone marrow‐derived mesenchymal stem cell defects in CD8+CD28– suppressor T‐lymphocyte induction in patients with immune thrombocytopenia and associated mechanisms
   Huiyuan Li et al, 2020, British Journal of Haematology CrossRef
8. Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders
   Yufeng Shang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
9. Allogeneic transplantation of mobilized dental pulp stem cells with the mismatched dog leukocyte antigen type is safe and efficacious for total pulp regeneration
   Koichiro Iohara et al, 2018, Stem Cell Research & Therapy CrossRef
10. Characteristics and clinical applications of Wharton’s jelly-derived mesenchymal stromal cells
    L.L. Liau et al, 2020, Current Research in Translational Medicine CrossRef
11. Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells Maintains and Partially Improves Visual Function in Patients with Advanced Retinitis Pigmentosa
    Tongtao Zhao et al, 2020, Stem Cells and Development CrossRef
12. Knowledge mapping of immune thrombocytopenia: a bibliometric study
    Feifeng Wu et al, 2023, Frontiers in Immunology CrossRef
13. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
    Yunfei Chen et al, 2024, Signal Transduction and Targeted Therapy CrossRef
14. Characterization of dynamical changes in vital signs during allogeneic human umbilical cord-derived mesenchymal stem cells infusion
    Yue Wang et al, 2023, Regenerative Therapy CrossRef
15. Umbilical cord mesenchymal stromal cell transplantations: A systemic analysis of clinical trials
    Alp Can et al, 2017, Cytotherapy CrossRef
16. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance via PTEN-mediated crosstalk between the PI3K/Akt and Erk/MAPKs signaling pathways in the skeletal muscles of db/db mice
    Guang Chen et al, 2020, Stem Cell Research & Therapy CrossRef
17. Insights on chronic immune thrombocytopenia pathogenesis: A bench to bedside update
    José Carlos Jaime-Pérez et al, 2021, Blood Reviews CrossRef